Blog
View this email in your browser
BLOG

Immuno-oncology updates in the virtual era – ASCO 2020

This year’s ASCO Annual Scientific Meeting took place between May 29-31, with the Education Program planned for August 8-10. Unlike previous years, when researchers, clinicians, cancer nurses, industry partners and patient advocates from all over the world would gather in Chicago, this year’s meeting took place virtually to curb the impact of the coronavirus disease 2019 (COVID-19) pandemic. Despite challenges imposed by the new meeting format, ASCO created the perfect platform to provide the opportunity for exchanging information and expertise on the most recent (immuno-)oncology advances, of which a comprehensive summary is given below.   

Emerging anti-cancer therapies
In addition to new developments regarding anti-programmed cell death protein 1 (PD-1) therapies, this year’s ASCO switched gears to
.. Read more
About CATO SMS: CATO SMS is a full-service clinical and regulatory contract research organization (CRO), specializing in complex areas such as (immuno-)oncology, advanced therapeutics and orphan diseases. CATO SMS has a center of excellence solely dedicated to oncology. With over 320 dedicated professionals with offices and operations in over 25 countries around the globe, the company brings a powerful blend of capabilities focused on supporting small and mid-sized biotech, top-tier pharmaceutical companies and investigator groups with their innovative research. We offer regulatory consulting and oncology drug development affairs in addition to clinical trial management services, with offices strategically located in close proximity from the FDA and EMA.
Website Website
LinkedIn LinkedIn
Twitter Twitter
Copyright © 2020 SMS-oncology BV, All rights reserved.


Our mailing address is:
info@sms-oncology.com

unsubscribe from this list    update subscription preferences 
 






This email was sent to newsletter@newslettercollector.com
why did I get this?    unsubscribe from this list    update subscription preferences
SMS-oncology · Walaardt Sacréstraat 401-403 · Schiphol, 1117 BM · Netherlands

Email Marketing Powered by Mailchimp